James Thomas

ORCID: 0000-0003-4805-4190 · 2 papers in corpus

rct

Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial

Obstetrics and gynecology ·doi:10.1097/AOG.0000000000005380

OBJECTIVE: To evaluate the safety and efficacy of elagolix 150 mg once-daily monotherapy in patients with heavy menstrual bleeding associated with uterine leiomyomas. METHODS: A phase 4, randomized, double-blind, placebo-controlled, 6-mont…

article 2012

The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites

·doi:10.1016/j.ygyno.2012.11.013

ObjectiveThe objectives of this study are to assess the clinical relevance and validity of the Functional Assessment of Chronic Illness Therapy-Ascites Index (FACIT-AI) in women with ovarian cancer and malignant ascites, and to modify the i…